Evidence Generation

Investing in health equity is a new endeavor that creates a set of planning, budgeting, and operational challenge. See how to make the business case.

With better RWE standards, organizations can make a more thorough evaluation and decide how DTx products can support care, cost, equity, and quality goals.

RTI Rarity™ supports targeted interventions and more accurate risk adjustment required for value-based contracts that entail more risk. Learn more.

Uncertainty is a key part of the process when it comes to decision-making in healthcare. Learn how to mitigate this in cost-effectiveness modeling here.

Race and ethnicity data lack robust consistency, availability, and accuracy. We help clients improve self-reported race & ethnicity data collection.

By designing digital health clinical trials for diversity, we can better meet patient needs and fulfill regulatory compliance measures. Learn more.

Research shows that exploring data on an extremely local level offers key insights that lead to more effective health equity interventions. Learn more.

With over 350k largely unregulated mobile health apps, an approach that can help with assessing digital therapeutics is scorecard methodology. Learn more.

Amy Helwig, MD, EVP joined a panel of provider, payer, and industry peers to discuss the current state of health equity. Learn about their discussion here.

Analytics is the workhorse of population health management. Learn how more sophisticated healthcare data analytics capabilities and tools extend PHM value.